FIP calls for broader role for pharmacists to provide focused interventions in NCDs in primary healthcare

The International Pharmaceutical Federation (FIP), a global federation representing about three million pharmacists and pharmaceutical scientists worldwide, is calling for a broader role to be played by pharmacists to prevent and control non-communicable diseases (NCDs) in primary healthcare.

NCDs are a serious healthcare risk, demanding new answers and requiring innovative and creative solutions. Here FIP sees the need for active participation of pharmacists to provide focused interventions, specialised counselling and care coordination, improving patient engagement to achieve better outcomes in NCDs like cardiovascular conditions, asthma/COPD, diabetes and cancer.

Pharmacists are already active as primary healthcare professionals in the community. We need to optimise and harness the roles of community pharmacists in the prevention, screening, referral, disease management and treatment optimisation in NCD patients, said Dominique Jordan, president, FIP.


In this regard the new FIP reference paper titled ‘Beating non communicable diseases in the community – The contribution of pharmacists’ will be released for the World Health Day on April, 7, through a social media campaign. The comprehensive report showcases evidence, best practice and policy options as well as a collection of country case studies. It is important that we proactively raise the awareness of policy makers, other health professions and the public about such roles, noted Dr Catherine Duggan, chief executive officer, FIP.


Further, FIP Bureau has appointed a policy committee that is currently drafting a policy statement on this subject to be discussed and voted upon at the Council meeting in September. This report is fully aligned with WHO strategy to prioritise primary healthcare and NCDs in particular, as cornerstones of sustainable and effective healthcare systems that can respond to the top health challenges and provide access to healthcare for all. Therefore, we see it offers pharmacists a valuable opportunity to be a key partner in that strategy, said FIP president Jordan.



Optimising health-related NCD outcomes requires collaborative care models, and reinforces the importance of multidisciplinary healthcare teams including pharmacists, physicians, nutritionists, nurses, physiotherapists and dentists, as well as patients and caregivers, said the FIP president.

The report states that community pharmacists are one of the most accessible primary healthcare professionals, offering quick and qualified support to patient needs. Even industry can contribute with solutions simplified medication regimens or packaging. There is also a scope for multi- partner initiatives for pharmacist training and workforce development.

With the pace of technological advances, new point of care devices can automate tasks. For instance, Devices like glucose monitoring, automatic blood-pressure cuffs and single-purpose ultrasound machines are seen to be helpful. Health information systems, cold chain solutions, and mobile health technologies are also much sought after. In addition, e-Learning and webinars facilitate broader access to constant information updated during training.



There are also imminent challenges sighted by FIP like sufficient qualified workforce with good communication and behavioural skills having enough time to take care of the multitude of patients.




Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

WhatsApp Group for Pharma Literati